97 related articles for article (PubMed ID: 3457752)
1. A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer.
Kavanagh JJ; Copeland LJ; Gershenson DM; Saul PB; Edwards CL
Gynecol Oncol; 1986 May; 24(1):23-6. PubMed ID: 3457752
[TBL] [Abstract][Full Text] [Related]
2. 4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
Bruzzone M; Chiara S; Falcone A; Graziani G; Conte PF; Rosso R
Chemioterapia; 1987 Apr; 6(2):137-9. PubMed ID: 3474080
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
Hakes TB; Daghestani AN; Dougherty JB; Weiselberg L; Raymond V
Cancer Treat Rep; 1985 May; 69(5):559-60. PubMed ID: 3859369
[No Abstract] [Full Text] [Related]
4. 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.
Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Cerri R; Risso M; Damasio E; Rossi E
Cancer; 1985 Apr; 55(7):1452-4. PubMed ID: 3856461
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Stuart NS; Cullen MH; Priestman TJ; Blackledge GR; Tyrrell CJ
Cancer Chemother Pharmacol; 1988; 21(4):351-4. PubMed ID: 3163529
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of 4-demethoxydaunorubicin with single i.v. doses.
Kaplan S; Martini A; Varini M; Togni P; Cavalli F
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1303-6. PubMed ID: 6962779
[TBL] [Abstract][Full Text] [Related]
7. Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.
Hochster HS; Green MD; Blum RH; Wernz JC; Speyer JL; Muggia FM
Invest New Drugs; 1986; 4(3):275-8. PubMed ID: 3469171
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial with oral idarubicin in advanced breast cancer.
Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
Invest New Drugs; 1986; 4(1):39-42. PubMed ID: 3457780
[TBL] [Abstract][Full Text] [Related]
9. Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
Tan CT; Hancock C; Steinherz P; Bacha DM; Steinherz L; Luks E; Winick N; Meyers P; Mondora A; Dantis E
Cancer Res; 1987 Jun; 47(11):2990-5. PubMed ID: 3471321
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.
Kavanagh JJ; Yeung KY; Savaraj N; Krakoff IH
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1187-9. PubMed ID: 3865774
[TBL] [Abstract][Full Text] [Related]
11. Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
Daghestani AN; Arlin ZA; Leyland-Jones B; Gee TS; Kempin SJ; Mertelsmann R; Budman D; Schulman P; Baratz R; Williams L
Cancer Res; 1985 Mar; 45(3):1408-12. PubMed ID: 3855696
[TBL] [Abstract][Full Text] [Related]
12. The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
Martoni A; Pacciarini MA; Pannuti F
Drugs Exp Clin Res; 1985; 11(2):127-31. PubMed ID: 3915281
[TBL] [Abstract][Full Text] [Related]
13. Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.
Martoni A; Pacciarini MA; Pannuti F
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):803-6. PubMed ID: 3862582
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
Bastholt L; Dalmark M
Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
[TBL] [Abstract][Full Text] [Related]
15. Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Wander HE; Meyer D; Schuff-Werner P; Nagel GA
Onkologie; 1986 Aug; 9(4):236-8. PubMed ID: 3531951
[No Abstract] [Full Text] [Related]
16. A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
Chisesi T; Capnist G; de Dominicis E; Dini E
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):681-4. PubMed ID: 3164269
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
Am J Clin Oncol; 1985 Oct; 8(5):377-9. PubMed ID: 3864366
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
[TBL] [Abstract][Full Text] [Related]
19. 4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
De Lena M; Brandi M; Bozzi D; Calabrese P; Romito S
Tumori; 1988 Feb; 74(1):65-70. PubMed ID: 3162625
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
